Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ncgc00356590-01
2. Sr-01000942221
3. Sr-01000942221-2
Molecular Weight | 197.841 g/mol |
---|---|
Molecular Formula | As2O3 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 0 |
Exact Mass | 197.82793 g/mol |
Monoisotopic Mass | 197.82793 g/mol |
Topological Polar Surface Area | 27.7 Ų |
Heavy Atom Count | 5 |
Formal Charge | 0 |
Complexity | 33.4 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
12
PharmaCompass offers a list of Arsenic Trioxide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Arsenic Trioxide manufacturer or Arsenic Trioxide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Arsenic Trioxide manufacturer or Arsenic Trioxide supplier.
PharmaCompass also assists you with knowing the Arsenic Trioxide API Price utilized in the formulation of products. Arsenic Trioxide API Price is not always fixed or binding as the Arsenic Trioxide Price is obtained through a variety of data sources. The Arsenic Trioxide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A TRISENOX manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of TRISENOX, including repackagers and relabelers. The FDA regulates TRISENOX manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. TRISENOX API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of TRISENOX manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A TRISENOX supplier is an individual or a company that provides TRISENOX active pharmaceutical ingredient (API) or TRISENOX finished formulations upon request. The TRISENOX suppliers may include TRISENOX API manufacturers, exporters, distributors and traders.
click here to find a list of TRISENOX suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A TRISENOX DMF (Drug Master File) is a document detailing the whole manufacturing process of TRISENOX active pharmaceutical ingredient (API) in detail. Different forms of TRISENOX DMFs exist exist since differing nations have different regulations, such as TRISENOX USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A TRISENOX DMF submitted to regulatory agencies in the US is known as a USDMF. TRISENOX USDMF includes data on TRISENOX's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The TRISENOX USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of TRISENOX suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The TRISENOX Drug Master File in Japan (TRISENOX JDMF) empowers TRISENOX API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the TRISENOX JDMF during the approval evaluation for pharmaceutical products. At the time of TRISENOX JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of TRISENOX suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing TRISENOX as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for TRISENOX API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture TRISENOX as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain TRISENOX and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a TRISENOX NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of TRISENOX suppliers with NDC on PharmaCompass.
TRISENOX Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of TRISENOX GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right TRISENOX GMP manufacturer or TRISENOX GMP API supplier for your needs.
A TRISENOX CoA (Certificate of Analysis) is a formal document that attests to TRISENOX's compliance with TRISENOX specifications and serves as a tool for batch-level quality control.
TRISENOX CoA mostly includes findings from lab analyses of a specific batch. For each TRISENOX CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
TRISENOX may be tested according to a variety of international standards, such as European Pharmacopoeia (TRISENOX EP), TRISENOX JP (Japanese Pharmacopeia) and the US Pharmacopoeia (TRISENOX USP).